Loading clinical trials...
Loading clinical trials...
The study quantitates behavioral challenges in mucopolysaccharidosis type I-III and parental coping strategies
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University Hospital Heidelberg
NCT06181136 · Mucopolysaccharidosis Type IIIA
NCT04571970 · Mucopolysaccharidosis Type II (MPS II)
NCT06022380 · Mucopolysaccharidosis Type II
NCT04284254 · Mucopolysaccharidosis Type IH (MPS IH, Hurler Syndrome), Mucopolysaccharidosis Type IH, and more
NCT01572636 · Mucopolysaccharidosis Type IH, MPS I, and more
University of Heidelberg
Heidelberg
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions